| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-73108 |
SAR439859
|
2114339-57-8 |
SAR439859 (Amcenestrant) is a potent, orally available, selective estrogen receptor degrader (SERD) with IC50 of 0.2 nM (ERα degradation). |
| PC-72965 |
GSK5182
|
877387-37-6 |
GSK5182 (GSK-5182) is a highly selective and orally active inverse agonist of estrogen-related receptor γ (ERRγ) with IC50 of 79 nM. |
| PC-72964 |
DN200434
|
2170732-60-0 |
DN200434 (DN-200434) is a highly potent (functional IC50=6 nM, binding IC50=40 nM), selective, biocompatible and orally available ERRγ inverse agonist. |
| PC-72606 |
Camizestrant
|
2222844-89-3 |
AZD9833 (Camizestrant) is an orally bioavailable, highly potent, next-generation selective estrogen receptor degrader (SERD) and antagonist with both EC50 of <1 nM (ERα receptor) in MCF7 cells. |
| PC-63293 |
LSZ102
|
2135600-76-7 |
LSZ102 is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) with ERα transcription IC50 of 6 nM and ERα degradation IC50 of 0.2 nM. |
| PC-60063 |
Enclomiphene citrate
|
7599-79-3 |
Enclomiphene citrate((E)-Clomifene, cis-Clomifene, RMI-16289, ICI-46476) is a nonsteroidal selective estrogen receptor modulator (SERM) that is under development for the treatment of male hypogonadism. |
| PC-45734 |
Elacestrant dihydrochloride
|
1349723-93-8 |
Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD). |
